Colorectal Cancer | Tumor

Every Patient Who Has a GI Cancer Should Be Tested for MSI-High Status

April 5th 2018, 9:43pm

With immunotherapy continuing to command headlines in the world of oncology, it’s no surprise that patients with a variety of cancers wonder whether the strategy might help them address and overcome their illnesses.

Upcoming Conference Discusses Colon Cancer in Young Adults

April 4th 2018, 10:56pm

Paying it Forward

March 30th 2018, 9:50pm

Funded posthumously by a "Jeopardy!" winner, an immunotherapy research project is under way.

Drug Pair Is Promising in Metastatic Colorectal Cancer

March 19th 2018, 11:45pm

The combination induced a 31 percent disease control rate (DCR) in patients with heavily-pretreated metastatic colorectal cancer (mCRC).

Genetic Testing Is Important for Both Patients and Family Members

March 19th 2018, 11:33pm

The understanding of genetic mutations, like tumors that are microsatellite instability-high (MSI-H), and the therapies that go along with them is transforming the world of colorectal cancer, according to John Marshall, M.D.

High Expectations for Immunotherapy in GI Cancers

March 18th 2018, 9:55pm

Immunotherapy may play a growing role in treating gastrointestinal cancers categorized as MSI-high.

A Cut Above Open Surgery

March 17th 2018, 9:17pm

Laparoscopy proves safer than open surgery and costs less than robotic resection for colorectal cancer.

Next-Generation Sequencing Platform Efficiently Detects MSI Status

March 13th 2018, 7:35pm

Next-generation sequencing could help identify MSI-H status in patients, which could have important implications for treatment plans.

Lumpy, Slimy and Inflamed

March 12th 2018, 7:08pm

A nasty stomach virus might have saved this survivor from colon cancer.

Colorectal Cancer Awareness Month: 'We Have Work to Do'

March 9th 2018, 9:24pm

Colorectal cancer expert John Marshall, M.D., shares his feelings about the month of March, which is Colorectal Cancer Awareness month.